Certain Restricted Stock Units of Nektar Therapeutics are subject to a Lock-Up Agreement Ending on 16-JAN-2017. These Restricted Stock Units will be under lockup for 90 days starting from 18-OCT-2016 to 16-JAN-2017. Details: The directors and executive officers have agreed that they will not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock, for a period of 90 days after the date of the final prospectus supplement without the prior written consent of J.P. Morgan Securities LLC.